Short Interest in Ion Beam Applications SA (OTCMKTS:IOBCF) Rises By 36.8%

Ion Beam Applications SA (OTCMKTS:IOBCF) was the target of a large increase in short interest during the month of January. As of January 15th, there was short interest totaling 930 shares, an increase of 36.8% from the December 31st total of 680 shares. Based on an average daily volume of 400 shares, the short-interest ratio is presently 2.3 days. Based on an average daily volume of 400 shares, the short-interest ratio is presently 2.3 days.

Ion Beam Applications Price Performance

Ion Beam Applications stock remained flat at $18.70 during mid-day trading on Friday. Ion Beam Applications has a twelve month low of $10.15 and a twelve month high of $19.00. The company has a fifty day simple moving average of $14.64 and a two-hundred day simple moving average of $14.19.

Ion Beam Applications Company Profile

Ion Beam Applications (OTCMKTS: IOBCF) is a Belgium-based medical technology company specializing in the development and deployment of particle therapy solutions for cancer treatment. Founded in 1986 and headquartered in Louvain-la-Neuve, the company is best known for its Proteus® line of proton therapy systems, which are designed to deliver precise, high-energy particle beams that target tumors while sparing healthy tissue. IBA oversees the full project lifecycle, from system design and manufacturing to installation, commissioning, and ongoing service support.

In addition to its flagship proton therapy business, IBA operates a diversified portfolio of technologies for medical and industrial applications.